AKESOgen

About:

AKESOgen is a biomarker, genomics, and pharmacogenomics contract research organization.

Website: http://www.akesogen.com/

Twitter/X: Akesogen

Top Investors: Georgia Research Alliance

Description:

AKESOgen is an integrated genomics, genetics and biobanking company that services the pharmaceutical, biotechnology, clinical, academic, and government sectors for clinical trials, diagnostic clinical testing and research. Based in greater Atlanta, GA, the company’s initial focus has been oncology and personalized medicine. AKESOgen’s Research Services and Clinical/Regulatory Services include providing high-throughput biomarker profiling, cytogenomic arrays, sequencing (both NGS and Sanger), genotyping and epigenomic analysis utilizing different types of markers (e.g. DNA, mRNA, miRNA, and methylation) to CLIA/GLP standards. Their expertise in genomics and process control as well as their customer commitment make AKESOgen an ideal partner to execute and deliver on your projects.

Total Funding Amount:

$1.85M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Norcross, Georgia, United States

Founded Date:

2010-01-01

Contact Email:

info(AT)akesogen.com

Founders:

Mark Bouzyk, Robert Boisjoli

Number of Employees:

11-50

Last Funding Date:

2019-04-03

IPO Status:

Private

Industries:

© 2025 bioDAO.ai